Endpoints News
FDA approves Rocket’s gene therapy for ultra-rare immune disease
A rare disease gene therapy from Rocket Pharmaceuticals has garnered FDA approval after an earlier rejection for manufacturing problems.
The FDA on Thursday granted accelerated approval to Rocket Pharma’s gene therapy …